1.Case of Yokukansan Efficaciousness for Weight Gain Due to Overeating Behavior Following Bariatric Surgery
Masahiro OHIRA ; Atsuhito SAIKI ; Takashi OHSHIRO ; Kazue SUZUKI ; Ichiro TATSUNO ; Kohji SHIRAI ; Tetsuo AKIBA
Kampo Medicine 2013;64(5):272-277
We report the case of a 51-year-old woman whose body weight was increased after bariatric surgery. She has been obese from a young age. When she was 30 years old, she developed type 2 diabetes mellitus. She was hospitalized for diabetic ketoacidosis at 45 years of age. She was diagnosed bulimic at 48 years of age, and body weight reduction with diet and exercise therapy became difficult because she was bulimic. Then, she underwent bariatric surgery and her body weight had reduced by 11 kg, 6 months after the surgery. However, her body weight began to increase again 7 months post surgery. At this time, her mental status had become unstable and she ate constantly in the afternoons. We administered yokukansan 5 g/day to treat her unstable mental status. Her body weight then decreased in accord with decreasing energy intake after the administration of yokukansan. She also became aware that her mental status was improving. Furthermore, her HbA1c (JDS) decreased from 8.7% to 7.1% after yokukansan treatment. In this case, it is possible that yokukansan suppressed the overeating by stabilizing her mental status, with the parallel decreases in body weight and HbA1c.
2.The Efficacy of Yokukansan in Obesity Patients on Overeating due to Anger (a Retrospective Study)
Masahiro OHIRA ; Atsuhito SAIKI ; Takashi YAMAGUCHI ; Haruki IMAMURA ; Yuta SATO ; Noriko BAN ; Hidetoshi KAWANA ; Ayako NAGUMO ; Ichiro TATSUNO ; Takaaki KOSUGE ; Tetsuo AKIBA
Kampo Medicine 2015;66(3):191-196
We previously reported that a case of yokukansan efficaciousness for weight gain due to overeating behavior following bariatric surgery. The reason is considered that yokukansan stabilized the patient's mental state. So, we proposed that administration of oriental medicines for mental state might be a new way of treating obesity. We investigated the efficacy of mazindol, bofutsushosan or yokukansan for obese patients. We retrospectively reviewed clinical data to identify patients administered mazindol, bofutsushosan or yokukansan for treatment of obesity. The inclusion criteria were patients tolerant to medicine for 3 months, and who could be administered yokukansan for anger. A total of 107 patients met these selection criteria. After 3 months of drug administration, significantly body weight reduction was observed in either the mazindol group or yokukansan group. We also selected and analyzed patients with diabetes mellitus to clarify the efficacy of these drugs for glucose metabolism. Reduction in HbA1c was not significant in the groups. These results suggest that mental health problems are very important for the treatment of obesity. And we suggest that oriental medicine is an effective treatment for mental health in obesity patients.